Pearl (hyriopsis cumingii)
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Pearl (hyriopsis cumingii)
- DrugBank Accession Number
- DB14249
- Background
Pearl (hyriopsis cumingii) is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Cultured Freshwater Pearl
- Hyriopsis Cumingii Cultured Pearl
- Margarita (Hyriopsis Cumingii)
- Pearl
- Pearl Powder
- Zhenzhu (Hyriopsis Cumingii)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cream Cream 9 mg/30mg Cutaneous Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US Patch Patch 4.8 mg/24mg Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Powder Powder 5 g/50g Dental Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Gluta Whitening Lazy Cream Pearl (hyriopsis cumingii) (1.5 g/30g) + Ascorbic acid (3 g/30g) + Glutathione (6 g/30g) + Glycyrrhiza glabra (7.5 g/30g) + Nicotinamide (3 g/30g) Cream Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Ma Ying Long Hemorrhoidal Pearl (hyriopsis cumingii) (0.25 g/10g) + Amber (0.1 g/10g) + Borneol (0.2 g/10g) + Bos taurus gallstone (0.1 g/10g) + Moschus berezovskii musk sac resin (0.15 g/10g) + Sodium borate decahydrate (0.2 g/10g) + Zinc carbonate (0.65 g/10g) Ointment Topical Trifecta Pharmaceuticals Usa, Llc. 2016-01-14 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Ma Ying Long Hemorrhoidal Pearl (hyriopsis cumingii) (0.25 g/10g) + Amber (0.1 g/10g) + Borneol (0.2 g/10g) + Bos taurus gallstone (0.1 g/10g) + Moschus berezovskii musk sac resin (0.15 g/10g) + Sodium borate decahydrate (0.2 g/10g) + Zinc carbonate (0.65 g/10g) Ointment Topical Trifecta Pharmaceuticals Usa, Llc. 2016-01-14 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- A75L5FZ40U
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Anus Neoplasms 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Cutaneous 9 mg/30mg Cream Cutaneous Ointment Topical Patch Cutaneous 4.8 mg/24mg Powder Dental 5 g/50g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53